Is a
Clinical Study attributes
NCT Number
Health Conditions in Trial
Trial Recruitment Size
8710
Trial Sponsor
Clinical Trial Start Date
March 1, 2023
0Primary Completion Date
April 1, 2024
0Study Completion Date
April 1, 2024
0Clinical Trial Study Type
Observational0
Observational Clinical Trial Type
Cohort0
Observational Study Perspective
Cross-Sectional0
Official Name
Machine Vision Based Machine Rating of MDS-UPDRS III0
Last Updated
June 18, 2023
0Study summary
The Movement Disorders Society (MDS) Unified Parkinson's Disease Rating Scale (UPDRS) Part III (MDS-UPDRS III) is the primary assessment method for motor symptoms in Parkinson's disease patients. Currently, movement disorder specialists conduct semi-quantitative scoring, which entails limitations such as subjectivity, weak sensitivity, and a limited number of professional physicians. This study, based on machine vision, establishes gold standard labels according to expert scoring. By using machine learning, we develop a machine rating model and compare the model's performance with gold standard rating and general clinical rating to investigate the accuracy of machine vision-based MDS-UPDRS III machine rating.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.